Literature DB >> 10901377

Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro.

F Pettersson1, K W Colston, A G Dalgleish.   

Abstract

Retinoids and vitamin D are known to exert important anti-tumour effects in a variety of cell types. In this study the effects of 9-cis-retinoic acid (9cRA) the vitamin D analogues EB1089 and CB1093 on three pancreatic adenocarcinoma cell lines were investigated. All compounds caused inhibition of in vitro growth but the vitamin D analogues were generally the more potent growth inhibitors. They were also more effective on their own than in combination with 9cRA. Growth arrest correlated with an increased proportion of cells in the G0/G1 phase. Apoptosis was induced in the three cell lines by 9cRA, whereas neither EB1089 nor CB1093 had this effect. Furthermore, addition of EB1089 or CB1093 together with 9cRA resulted in significantly reduced apoptosis. Our results show that retinoic acids as well as vitamin D analogues have inhibitory effects on pancreatic tumour cells but different and antagonistic mechanisms seem to be employed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901377      PMCID: PMC2363480          DOI: 10.1054/bjoc.2000.1281

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  44 in total

1.  Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice.

Authors:  K Koshizuka; T Kubota; J Said; M Koike; L Binderup; M Uskokovic; H P Koeffler
Journal:  Anticancer Res       Date:  1999 Jan-Feb       Impact factor: 2.480

2.  Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells.

Authors:  E Elstner; M J Campbell; R Munker; P Shintaku; L Binderup; D Heber; J Said; H P Koeffler
Journal:  Prostate       Date:  1999-08-01       Impact factor: 4.104

3.  Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis.

Authors:  C Danielsson; H Törmä; A Vahlquist; C Carlberg
Journal:  Int J Cancer       Date:  1999-05-05       Impact factor: 7.396

Review 4.  Retinoid-induced apoptosis in normal and neoplastic tissues.

Authors:  L Nagy; V A Thomazy; R A Heyman; P J Davies
Journal:  Cell Death Differ       Date:  1998-01       Impact factor: 15.828

5.  BCL-2 gene family and the regulation of programmed cell death.

Authors:  S J Korsmeyer
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

Review 6.  Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D.

Authors:  S Y James; M A Williams; A C Newland; K W Colston
Journal:  Gen Pharmacol       Date:  1999-01

7.  EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells.

Authors:  I S Mathiasen; K W Colston; L Binderup
Journal:  J Steroid Biochem Mol Biol       Date:  1993-09       Impact factor: 4.292

Review 8.  Transcriptional regulation of the p21((WAF1/CIP1)) gene.

Authors:  A L Gartel; A L Tyner
Journal:  Exp Cell Res       Date:  1999-02-01       Impact factor: 3.905

9.  The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques.

Authors:  N J Philpott; A J Turner; J Scopes; M Westby; J C Marsh; E C Gordon-Smith; A G Dalgleish; F M Gibson
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

10.  Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines.

Authors:  S Kawa; K Yoshizawa; M Tokoo; H Imai; H Oguchi; K Kiyosawa; T Homma; T Nikaido; K Furihata
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

View more
  20 in total

1.  Vitamin D-binding protein and pancreatic cancer: a nested case-control study.

Authors:  Marina R Piper; D Michal Freedman; Kim Robien; William Kopp; Helen Rager; Ronald L Horst; Rachael Z Stolzenberg-Solomon
Journal:  Am J Clin Nutr       Date:  2015-04-22       Impact factor: 7.045

2.  Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.

Authors:  Chen Yuan; Zhi Rong Qian; Ana Babic; Vicente Morales-Oyarvide; Douglas A Rubinson; Peter Kraft; Kimmie Ng; Ying Bao; Edward L Giovannucci; Shuji Ogino; Meir J Stampfer; John Michael Gaziano; Howard D Sesso; Julie E Buring; Barbara B Cochrane; Rowan T Chlebowski; Linda G Snetselaar; JoAnn E Manson; Charles S Fuchs; Brian M Wolpin
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

3.  Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.

Authors:  Kun-Chun Chiang; Chun-Nan Yeh; Jun-Te Hsu; Ta-sen Yeh; Yi-yin Jan; Chun-Te Wu; Huang-Yang Chen; Shyh-Chuan Jwo; Masashi Takano; Atsushi Kittaka; Horng-Heng Juang; Tai C Chen
Journal:  Cell Cycle       Date:  2013-04-02       Impact factor: 4.534

4.  25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).

Authors:  Katherine Van Loon; Kouros Owzar; Chen Jiang; Hedy L Kindler; Mary F Mulcahy; Donna Niedzwiecki; Eileen M O'Reilly; Charles Fuchs; Federico Innocenti; Alan P Venook
Journal:  J Natl Cancer Inst       Date:  2014-08-06       Impact factor: 13.506

5.  Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Authors:  Rachael Z Stolzenberg-Solomon; Eric J Jacobs; Alan A Arslan; Dai Qi; Alpa V Patel; Kathy J Helzlsouer; Stephanie J Weinstein; Marjorie L McCullough; Mark P Purdue; Xiao-Ou Shu; Kirk Snyder; Jarmo Virtamo; Lynn R Wilkins; Kai Yu; Anne Zeleniuch-Jacquotte; Wei Zheng; Demetrius Albanes; Qiuyin Cai; Chinonye Harvey; Richard Hayes; Sandra Clipp; Ronald L Horst; Lonn Irish; Karen Koenig; Loic Le Marchand; Laurence N Kolonel
Journal:  Am J Epidemiol       Date:  2010-06-18       Impact factor: 4.897

6.  Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells.

Authors:  Jianwei Zhang; Hongyan Zhang; Xia Zhang; Zhonghe Yu
Journal:  Cytotechnology       Date:  2012-10-16       Impact factor: 2.058

Review 7.  Vitamin D for the prevention and treatment of pancreatic cancer.

Authors:  Kun-Chun Chiang; Tai C Chen
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

8.  Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic cancer.

Authors:  C D Blanke; T M Beer; K Todd; M Mori; M Stone; C Lopez
Journal:  Invest New Drugs       Date:  2008-10-09       Impact factor: 3.850

9.  Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.

Authors:  Rachael Z Stolzenberg-Solomon; Richard B Hayes; Ron L Horst; Kristin E Anderson; Bruce W Hollis; Debra T Silverman
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

Review 10.  Vitamin D and pancreatic cancer.

Authors:  Rachael Z Stolzenberg-Solomon
Journal:  Ann Epidemiol       Date:  2008-05-27       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.